Proxy Votes Now

Home › Upcoming votes › Apimeds Pharmaceuticals US, Inc.

Apimeds Pharmaceuticals US, Inc. Annual Meeting December 23, 2026: What's on the Ballot

No fund votes on record from prior seasons.

Read the proxy statement on EDGAR

Proxy summary

Summary, checked against the proxy statement. Each point is backed by a passage of the filing, shown under the point; figures under “Last year’s votes” come from the company’s Form 8-K. Read the proxy statement before relying on it.

Virtual annual meeting: election of four current directors whose board seats are set by a settlement agreement, auditor ratification and an adjournment proposal.

Key points

What changed from last year

What’s on the ballot

Ballot read from the proxy statement and checked. As listed in Apimeds Pharmaceuticals US, Inc.’s proxy statement, with the board’s recommendation on each item.

#ItemProposed byBoard recommends
1 ELECTION OF DIRECTORS
Director election
Board For
2 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Auditor
Board For
3 ADJOURNMENT PROPOSAL
Adjournment
Board For

Filings for this meeting

About this page

The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.